AstraZeneca is no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.
People pose with syringe with needle in front of displayed AstraZeneca logo in this illustration taken, December 11, 2021. REUTERS/Dado Ruvic/Illustrationis no longer pursuing U.S. approval of its COVID-19 vaccine, Chief Executive Pascal Soriot said in a media call on Thursday.
Demand for vaccines in the country is declining and the market is well served by the mRNA shots, he said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
AstraZeneca Drops Plan to Sell Covid-19 Vaccine in U.S.AstraZeneca said it had dropped plans to submit its Covid-19 vaccine to the Food and Drug Administration for approval
Weiterlesen »
Several candidates who questioned 2020 results will now become states' chief election officialWhile their duties vary based on the state, in most states, secretaries of state serve as the administrator of elections.
Weiterlesen »
The Latest COVID-19 Variants Can Evade Vaccine Protection, According to New DataExperts are studying new variants against which most people may not have much immunity—even if they're been vaccinated or have had COVID-19
Weiterlesen »
China's manufacturing hub Guangzhou partially locked down as Covid outbreak widens | CNNChina's southern metropolis of Guangzhou has locked down a third district, as authorities rush to stamp out a widening Covid outbreak and avoid activating the kind of citywide lockdown that devastated Shanghai earlier this year.
Weiterlesen »
China's Guangzhou brings back mass testing to fight city's worst COVID outbreakMillions of residents of China's southern manufacturing hub of Guangzhou were told on Wednesday to get tested for COVID-19, as infections topped two thousand for two days running in the city's worst outbreak so far.
Weiterlesen »